Serina Therapeutics (2BO) Q2 2024 Earnings Report
DE:2BO Q2 2024 EPS Results
- Actual EPS
- EUR 0.44
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 2.13
DE:2BO Q2 2024 Revenue Results
- Actual Revenue
- EUR 43.81K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +466.67%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/09/2024
- Time
- After Close
- Conference Call
- Friday, August 9, 2024
DE:2BO Upcoming Earnings
Serina Therapeutics's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2BO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -0.29- | -0.39 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.40-0.47 | -0.57 | 16.67% (+0.09) | |
| May 14, 2026 | 2026 (Q1) | -0.38-0.50 | -0.42 | -18.37% (-0.08) | |
| Mar 25, 2026 | 2025 (Q4) | -0.43-0.27 | -0.97 | 72.57% (+0.70) | |
| Nov 13, 2025 | 2025 (Q3) | -0.46-0.39 | 0.11 | -443.51% (-0.50) | |
| Aug 11, 2025 | 2025 (Q2) | -0.37-0.57 | 0.44 | -228.91% (-1.01) | |
| May 08, 2025 | 2025 (Q1) | -0.53-0.42 | -2.91 | 85.51% (+2.48) | |
| Mar 24, 2025 | 2024 (Q4) | 0.36-0.97 | -2.75 | 64.72% (+1.78) | |
| Nov 12, 2024 | 2024 (Q3) | ―0.11 | -4.3 | 102.62% (+4.41) | |
| Aug 09, 2024 | 2024 (Q2) | ―0.44 | -2.13 | 120.70% (+2.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed